Clinical Trial Update: The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial updating results on vildagliptin-based treatment versus sulfonylurea for glycemic variability, oxidative stress, GLP-1, and endothelial function i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulfonylurea (sulfonylurea)
• Vildagliptin-based treatment (vildagliptin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED